SmithKline Beecham
GSK Exits Haleon with $1.52 Billion Stake Sale
GSK, Haleon, stake sale, divestment, healthcare, pharmaceuticals, consumer health, spin-off, fundraising
GSK’s Vaccine Sales Surge Continues, Boosting 2024 Outlook
GSK, GlaxoSmithKline, vaccine sales, 2024 forecasts, pharmaceutical industry, revenue growth, COVID-19 vaccines, Shingrix, healthcare sector
GSK Files Lawsuit Against Pfizer and BioNTech for Alleged COVID-19 Vaccine Patent Violation
GSK, Pfizer, BioNTech, COVID-19, patent infringement, vaccine, lawsuit, intellectual property
AstraZeneca Joins Price Cap Movement for Inhalers Following Boehringer Investigation
Evaluation, Inhaler, AstraZeneca, SmithKline Beecham, Prices